Innovation is the engine of progress in dementia research, fueling breakthroughs that move us closer to effective treatments, prevention strategies, and ultimately, cures. The development of disease-modifying therapies marks a new era — one that demands an intensified focus on innovation in brain health and beyond just basic science.

From clinical applications to new approaches in care and technology, innovation is accelerating the discovery of new treatments, enhancing diagnostic capabilities, and refining prevention strategies. The landscape is evolving rapidly, with advances in biomarkers, artificial intelligence, precision medicine and novel therapeutic approaches reshaping what is possible.

To sustain this momentum, we must foster an ecosystem that encourages collaboration, incentivizes risk-taking, and integrates scientific, regulatory and commercial efforts. The World Dementia Council will convene a series of dialogues and meetings to bring together leaders in innovation, discuss the public policy environment, and explore how we can accelerate progress. Our aim is to develop a series of papers that examine not only scientific breakthroughs, but also how innovation can drive equity, improve care, and address the public policy challenges facing the global dementia community.

  • Innovation Events

    The World Dementia Council convenes innovation dialogues, roundtables, and workshops with scientific leaders, industry partners, policymakers, and practitioners. These sessions examine how innovation is driving advances in science and public policy. Participants share experience from different systems and sectors, identifying what enables innovation to move from discovery to real-world delivery — and where policy, infrastructure, or investment environments need to evolve to support responsible and equitable implementation.

  • Read About the Project

    Scientific and technological advances are expanding what is possible in dementia — from biomarkers and artificial intelligence to new therapeutic approaches and care innovations. The challenge is to ensure that these developments translate into real benefit for patients. The WDC is convening a series of dialogues to examine how innovation can be accelerated and adopted responsibly, and what policy, regulatory, and system conditions are needed to support progress.